Previous Article | Next Article 
J Virol, March 1998, p. 2516-2518, Vol. 72, No. 3
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Measles Virus DNA Vaccination: Antibody Isotype Is Determined
by the Method of Immunization and by the Nature of both the
Antigen and the Coimmunized Antigen
Alicia I.
Cardoso,
Nathalie
Sixt,
Agnes
Vallier,
Joel
Fayolle,
Robin
Buckland, and
T. Fabian
Wild*
INSERM Unit 404 "Immunity and
Vaccination," Institut Pasteur de Lyon, 69365 Lyon Cedex 07, France
Received 29 September 1997/Accepted 8 December 1997
 |
ABSTRACT |
Plasmids encoding the measles virus hemagglutinin (HA) and
nucleoprotein (NP) proteins inoculated into the skin of BALB/c mice by the gene gun method induced both humoral and cytotoxic lymphocyte class I-restrict- ed immune responses.
Although intramuscular immunization induces the immunoglobulin G2a
(IgG2a) antibody isotype for both antigens, with gene gun
immunization, the NP still generated mainly IgG2a and the major isotype
induced by the HA was IgG1. Interestingly, gene gun coimmunization of
HA and NP plasmids resulted in a dominant IgG1 HA response and the
switching of antibodies generated against the NP to the IgG1 isotype.
 |
TEXT |
The initial studies showing that
injection of DNA into muscle induces an immune response to the encoded
protein opened a new approach to vaccination (for reviews, see
references 19 and 22). Recent studies suggest that
inoculated muscle cells probably act only as a source of antigen and
that immune priming takes place elsewhere in the body (14).
For example, excision of an injected muscle a few minutes after DNA
inoculation did not affect antibody and cytotoxic T-lymphocyte (CTL)
responses (21). Thus, it may be interesting to examine other
DNA delivery systems to study how the immune system responds to DNA
vaccination. One alternative system involves precipitating DNA onto
gold beads which are then propelled into the skin by means of
pressurized helium gas (12). When such a system is used,
less DNA is required, but unlike the case with intramuscular
inoculations, the response is Th2-like, generating immunoglobulin G1
(IgG1) antibodies (17). More recent observations suggest
that this is probably due to the mode of inoculation rather than the
route (10).

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 1.
Anti-MV HA isotype of antibodies induced in BALB/c,
DBA/2 (H-2d), C3H (H-2k),
and C57/Black (H-2b) mice immunized with 0.5, 2, or 5 µg of pV1J-HA by epidermal gene gun. Sera were collected 3 weeks
after the immunization. Sera from mice immunized with a control pV1J
had means ± standard deviations of 158 ± 198 ng/ml for
IgG1 anti-HA antibodies (n = 11) and 10 ± 18 ng/ml for IgG2a anti-HA antibodies (n = 11). Data
represent individual animals.
|
|
We have been studying DNA vaccination against the paramyxovirus
measles virus (MV). This disease is one of the primary causes of infant
mortality in developing countries, and there is an urgent need for an
effective vaccine in infants, as the present live attenuated vaccine is
inefficient in the presence of maternal antibodies. Our previous
studies established that in a mouse model at least three MV
proteins play a role in protection (23). Both glycoproteins,
hemagglutinin (HA) and fusion, induce neutralizing antibodies (9,
11), and HA and nucleoprotein (NP) induce CTLs (3, 4),
which do not protect against infection but help in recovery
(5). In our previous study on DNA vaccination, we showed
that intramuscular inoculation of DNAs coding for the MV HA and NP
(pV1J-HA and pV1J-NP [6]) induced class I-restricted CTLs and a humoral response corresponding to a Th1 response
(6). In the present study, we have extended our observations
to compare the same plasmids' ability to induce an immune response
when they are delivered into the skin by a gene gun (Bio-Rad, Ivry sur
Seine, France). Gold beads were coated with DNA as follows:
approximately 30 mg of gold powder (1.0-µm gold beads; Bio-Rad) was
mixed with 100 µl of 0.1 M spermidine (Sigma, L'Isle D'Abeau,
France). After sonication, 0.5, 2, or 5 µg of plasmid DNA was added
per mg of gold powder, and then 200 µl of 2.5 M CaCl2 was
added to the mixture, with gentle vortexing. Pellets were washed three
times and suspended in cold 100% ethanol. Tubes containing dried
DNA-coated gold beads were stored at 4°C.
Immune response to MV HA DNA.
Six- to eight-week-old
female BALB/c mice (Iffa-Credo, Domaine des Oncins, France)
were immunized via the shaved abdominal epidermis one to three
times at 21-day intervals with 0.5, 2, or 5 µg of pV1J-HA DNA/mg of
gold beads. Two gene gun inoculations (each containing 0.5 mg of gold
beads) were given for each dose. The antibody levels measured by
enzyme-linked immunosorbent assay, as previously described
(6), reached a plateau after two inoculations and did not
significantly increase with a third inoculation (result not shown).
Our previous studies with intramuscular inoculation established
that pV1J-HA induced IgG2a antibodies which are associated
with a Th1-type response. When we studied the antibody isotype
induced
in BALB/c by the gene gun immunization, we observed that
it was mainly
IgG1 (Fig.
1). These data are similar to those described
for influenza
hemagglutinin by Feltquate et al. (
10). The antibody
isotype
did not vary with time after immunization, number of immunizations,
or
the amount of plasmid used (data not shown) and was not influenced
by
genetic background, as pV1J-HA-immunized DBA/2
(
H-2d), C3H (
H-2k), and
C57/Black (
H-2b) mice induced mainly the IgG1
isotype (Fig.
1).
To study CTL activity, spleen cells from the immunized mice were
stimulated in vitro and analyzed in a cytolytic assay as
previously
described (
6). Despite the apparent Th2-type response,
good
memory CTL responses were obtained with all protocols used,
even when
responses were measured just 8 days after a single immunization
(Fig.
2), and persisted for several months.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 2.
Anti-MV HA and NP CTL response after immunization with
pV1J-HA or -NP, respectively. BALB/c mice were immunized with 0.5 (circle), 2 (triangle), or 5 (square) µg of pV1J-HA by
epidermal gene gun one (a, d), two (b, e), or three (c, f) times at
3-week intervals. The spleen cells were removed 3 weeks (continuous
line) or 8 days (dotted line) after the last immunization. After in
vitro stimulation with P815-HA or -NP cells, respectively, lysis was
measured on P815-HA or -NP cells, and P815 cells were used as a
negative control. The results show the specific lysis of targets at
graded effector/target ratios. Each curve represents an individual
animal.
|
|
Immune response to MV NP DNA.
BALB/c mice were immunized with
pV1J-NP with the gene gun and a similar schedule of immunizations. The
antibody response with the different number of doses and different
plasmid concentrations was similar to that observed for HA, i.e.,
increased levels after one boost. Similar antibody levels were induced
in the range of 0.5 to 5 µg of DNA (data not shown). As was
previously shown by intramuscular inoculation (6), the
antibody isotype induced was mainly IgG2a (Fig.
3), in contrast to the HA results. One explanation for this could be that as the NP is a cytosolic protein and
the HA is membrane bound, the potential processing and presentation of
the two proteins may be different. However, the same argument would be
valid for intramuscular inoculation. Furthermore, it has been reported
that gene gun immunization with influenza NP induces a Th2 response
(17), so clearly the directed differentiation of T cells is
more complicated than a simple distinction between cytosol and
membrane-bound proteins. The two methods of immunization (intramuscular versus gene gun) target different cell types,
possibly influencing the T-cell response. Furthermore, 9 weeks after
immunization, one-third of the 18 mice analyzed showed increased levels
of anti-NP IgG1 over IgG2a, regardless of the quantity of DNA injected
or the number of inoculations (data not shown). CTL responses were also
high, even after a single inoculation (Fig. 2).

View larger version (53K):
[in this window]
[in a new window]
|
FIG. 3.
Anti-MV NP antibody response as measured by
enzyme-linked immunosorbent assay in BALB/c mice immunized with 5 µg
of pV1J-NP by epidermal gene gun. Sera were collected 3 weeks after
immunization. Each pair of bars represents an individual animal. Sera
from mice immunized with a control pV1J had means ± standard
deviations of 13 ± 45 ng/ml of IgG1 anti-NP antibodies
(n = 11) and 83 ± 276 ng/ml of IgG2a anti-NP
antibodies (n = 11).
|
|
Coimmunization of HA and NP DNA.
Our results show that when
injected by the gene gun, the different MV proteins induce different
antibody isotypes. This phenomenon has been suggested to parallel the
induction of Th1 and Th2 pathways (1). The pathway taken has
been shown to be influenced by the induction of certain cytokines. To
determine if coimmunization of these two plasmids would influence the
isotype of the antibody response, BALB/c mice were immunized with a
mixture of pV1J-HA and pV1J-NP in ratios of 1:1, 4:1, or 1:4 while the
total amount of DNA was kept constant (5 µg).
Measurement of the anti-HA isotype antibody in mice vaccinated with the
different mixtures showed it to be mainly IgG1, similar
to that for HA
alone (data not shown). In contrast, the anti-NP
antibodies switched
from the IgG2a to the IgG1 isotype after coimmunization
(Fig.
4). The proximity of expression of the
two antigens was
not important in this switching effect, as when
pV1J-HA and -NP
were inoculated separately in different areas of the
skin, the
antibody response induced 3 weeks later was the same as that
induced
when the mixture was inoculated (Fig.
4). When analyzed 6 weeks
later, only one of six mice showed IgG2a predominance.

View larger version (56K):
[in this window]
[in a new window]
|
FIG. 4.
Relationship between the isotype of anti-NP antibodies
in sera from mice immunized with 5 µg of pV1J-NP or mixtures of
pV1J-HA and pV1J-NP at ratios of 1:1, 4:1, and 1:4 so that the total
quantity of DNA/mg gold beads was 5 µg, or pV1J-HA and pV1J-NP
injected in different skin area. BALB/c mice were immunized by
epidermal gene gun. Sera were collected 3 weeks after immunization.
Data are results for individual animals.
|
|
Cytokines have been used to direct the immune response in several
studies. Expression of interleukin-12 either alone or with
immunizing
antigens can increase protection against microbial
pathogens
(
2) or tumors in animal models (
13,
18), in
parallel
with a Th1 response. Expression or addition of interleukin-4
with
the immunogen induces a Th2 response (
16,
20). The
local concentrations
of the cytokines in the initial priming of the
immune response
are probably critical, as once the T cells have been
committed,
they cannot be modified. Although some studies have
suggested
the possibility of Th1 and Th2 switching, a more recent study
has shown that once differentiated, T cells cannot switch
(
15).
In agreement with this, Feltquate et al.
(
10) have shown that
initial immunization establishes the
Th-cell type of the immune
response and that this is not modified by
subsequent alternative
methods of immunization.
Acute viral infections induce a Th1 response, whereas soluble proteins
favor a Th2 response (
7). When tetanus toxoid was
administered 1 day after viral infection, the response to this
soluble
protein changed from Th2 to Th1 (
8). Presumably, this
change
is due to the domination by the cytokines induced by the
viral
infection of those produced by the tetanus toxoid. In our
studies, we
observed that after the coexpression of MV HA and
NP, the HA-induced
Th2 response was dominant. These observations
will obviously have an
impact on DNA vaccination, as DNAs coding
for several pathogens should
ideally be administered concomitantly.
 |
ACKNOWLEDGMENTS |
These studies were supported by grants from Merck Research
Laboratories, West Point, Pa., the World Health Organization, and the
French Rhône-Alpes Région (Emergence Programme). R.B. is a
C.N.R.S. scientist.
We thank F. Henry for animal care and B. Maret for editorial
assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: INSERM
Unit 404 "Immunity and Vaccination," Institut Pasteur de Lyon, Ave.
Tony Garnier, 69365 Lyon Cedex 07, France. Phone: (33) 4 72 72 25 53. Fax: (33) 4 72 72 25 67. E-mail: wild{at}lyon151.inserm.fr
 |
REFERENCES |
| 1.
|
Abbas, A. K.,
K. M. Murphy, and A. Sher.
1996.
Functional diversity of helper T lymphocytes.
Nature
383:787-793[Medline].
|
| 2.
|
Afonso, L. C. C.,
T. M. Scharton,
L. Q. Vieira,
M. Wysocka,
G. Trichieri, and P. Scott.
1994.
The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.
Science
263:235-237[Abstract/Free Full Text].
|
| 3.
|
Beauverger, P.,
R. Buckland, and T. F. Wild.
1993.
Measles virus antigens induce both type-specific and canine distemper virus cross-reactive cytotoxic T lymphocytes in mice: localisation of a common Ld-restricted nucleoprotein epitope.
J. Gen. Virol.
74:2357-2363[Abstract/Free Full Text].
|
| 4.
|
Beauverger, P.,
R. Buckland, and T. F. Wild.
1994.
Measles virus hemagglutinin induces an Ld-restricted CD8+ cytotoxic T lymphocyte response to two specific epitopes.
Virology
200:281-283[Medline].
|
| 5.
|
Beauverger, P.,
A. I. Cardoso,
L. Daviet,
R. Buckland, and T. F. Wild.
1996.
Analysis of the contribution of CTL epitopes in the immunobiology of Morbillivirus infection.
Virology
219:133-139[Medline].
|
| 6.
|
Cardoso, A. I.,
M. Blixenkrone-Moller,
J. Fayolle,
M. Liu,
R. Buckland, and T. F. Wild.
1996.
Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity.
Virology
225:293-299[Medline].
|
| 7.
|
Coutelier, J.-P.,
J. T. M. Van Der Logt,
F. W. A. Heessen,
G. Warnier, and J. Van Snick.
1987.
IgG2a restriction of murine antibodies elicited by viral infections.
J. Exp. Med.
165:64-69[Abstract/Free Full Text].
|
| 8.
|
Coutelier, J.-P.,
J. T. M. Van Der Logt,
F. W. A. Heessen,
A. Vink, and J. Van Snick.
1988.
Virally induced modulation of murine IgG antibody subclasses.
J. Exp. Med.
168:2373-2378[Abstract/Free Full Text].
|
| 9.
|
Drillien, R.,
D. Spehner,
A. Kirn,
P. Giraudon,
R. Buckland,
T. F. Wild, and J. P. Lecocq.
1988.
Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or fusion protein.
Proc. Natl. Acad. Sci. USA
85:1252-1256[Abstract/Free Full Text].
|
| 10.
|
Feltquate, D. M.,
S. Heaney,
R. G. Webster, and H. Robinson.
1997.
Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization.
J. Immunol.
158:2278-2284[Abstract].
|
| 11.
|
Giraudon, P., and T. F. Wild.
1995.
Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity.
Virology
144:46-58.
|
| 12.
|
Haynes, J. R.,
D. E. McCabe,
W. F. Swain,
G. Widera, and J. T. Fuller.
1996.
Particle-mediated nucleic acid immunization.
J. Biotechnol.
44:37-42[Medline].
|
| 13.
|
Irvine, K. R.,
J. B. Rao,
S. A. Rosenberg, and N. P. Restifo.
1996.
Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases.
J. Immunol.
156:238-245[Abstract].
|
| 14.
|
Manickan, E.,
S. Kanangat,
R. J. D. Rouse,
Z. Yu, and B. T. Rouse.
1997.
Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells.
J. Leukocyte Biol.
61:125-132[Abstract].
|
| 15.
|
Mocci, S., and R. L. Coffman.
1997.
The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations.
J. Immunol.
158:1559-1564[Abstract].
|
| 16.
|
Moran, T. M.,
H. Isobe,
A. Fernandez-Sesma, and J. L. Schulman.
1996.
Interleukin-4 causes delayed virus clearance in influenza virus-infected mice.
J. Virol.
70:5230-5235[Abstract/Free Full Text].
|
| 17.
|
Pertmer, T. M.,
T. R. Roberts, and J. R. Haynes.
1996.
Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery.
J. Virol.
70:6119-6125[Abstract].
|
| 18.
|
Rakhmilevich, A. L.,
J. Turner,
M. J. Ford,
D. McCabe,
W. H. Sun,
P. M. Sondel,
K. Grota, and N.-S. Yang.
1996.
Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors.
Proc. Natl. Acad. Sci. USA
93:6291-6296[Abstract/Free Full Text].
|
| 19.
|
Robinson, H. L.
1997.
Nucleic acid vaccines: an overview.
Vaccine
15:785-787[Medline].
|
| 20.
|
Sharma, D. P.,
A. J. Ramsay,
D. J. Maguire,
M. S. Rolph, and I. A. Ramshaw.
1996.
Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo.
J. Virol.
70:7103-7107[Abstract/Free Full Text].
|
| 21.
|
Torres, C. A. T.,
A. Iwasaki,
B. H. Barber, and H. L. Robinson.
1997.
Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations.
J. Immunol.
158:4529-4532[Abstract].
|
| 22.
|
Ulmer, J. B.,
J. C. Sadoff, and M. A. Liu.
1996.
DNA vaccines.
Curr. Opin. Immunol.
8:531-536[Medline].
|
| 23.
|
Wild, T. F.,
A. Bernard,
D. Spehner, and R. Drillien.
1992.
Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice.
J. Gen. Virol.
73:359-367[Abstract/Free Full Text].
|
J Virol, March 1998, p. 2516-2518, Vol. 72, No. 3
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Liang, R., van den Hurk, J. V., Landi, A., Lawman, Z., Deregt, D., Townsend, H., Babiuk, L. A., van Drunen Littel-van den Hurk, S.
(2008). DNA prime protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge. J. Gen. Virol.
89: 453-466
[Abstract]
[Full Text]
-
Guillaume, V., Contamin, H., Loth, P., Georges-Courbot, M.-C., Lefeuvre, A., Marianneau, P., Chua, K. B., Lam, S. K., Buckland, R., Deubel, V., Wild, T. F.
(2004). Nipah Virus: Vaccination and Passive Protection Studies in a Hamster Model. J. Virol.
78: 834-840
[Abstract]
[Full Text]
-
Etchart, N., Desmoulins, P.-O., Chemin, K., Maliszewski, C., Dubois, B., Wild, F., Kaiserlian, D.
(2001). Dendritic Cells Recruitment and In Vivo Priming of CD8+ CTL Induced by a Single Topical or Transepithelial Immunization Via the Buccal Mucosa with Measles Virus Nucleoprotein. J. Immunol.
167: 384-391
[Abstract]
[Full Text]
-
Ohashi, T., Hanabuchi, S., Kato, H., Tateno, H., Takemura, F., Tsukahara, T., Koya, Y., Hasegawa, A., Masuda, T., Kannagi, M.
(2000). Prevention of Adult T-Cell Leukemia-Like Lymphoproliferative Disease in Rats by Adoptively Transferred T Cells from a Donor Immunized with Human T-Cell Leukemia Virus Type 1 Tax-Coding DNA Vaccine. J. Virol.
74: 9610-9616
[Abstract]
[Full Text]
-
Weiss, R., Leitner, W. W., Scheiblhofer, S., Chen, D., Bernhaupt, A., Mostbock, S., Thalhamer, J., Lyon, J. A.
(2000). Genetic Vaccination against Malaria Infection by Intradermal and Epidermal Injections of a Plasmid Containing the Gene Encoding the Plasmodium berghei Circumsporozoite Protein. Infect. Immun.
68: 5914-5919
[Abstract]
[Full Text]
-
Schlereth, B., Germann,, P.-G., ter Meulen, V., Niewiesk, S.
(2000). DNA vaccination with both the haemagglutinin and fusion proteins but not the nucleocapsid protein protects against experimental measles virus infection. J. Gen. Virol.
81: 1321-1325
[Abstract]
[Full Text]
-
Fensterle, J., Grode, L., Hess, J., Kaufmann, S. H. E.
(1999). Effective DNA Vaccination Against Listeriosis by Prime/Boost Inoculation with the Gene Gun. J. Immunol.
163: 4510-4518
[Abstract]
[Full Text]
-
Bernard, A., Cohen, R., Khuth, S.-T., Vedrine, B., Verlaeten, O., Akaoka, H., Giraudon, P., Belin, M.-F.
(1999). Alteration of the Leptin Network in Late Morbid Obesity Induced in Mice by Brain Infection with Canine Distemper Virus. J. Virol.
73: 7317-7327
[Abstract]
[Full Text]
-
Fennelly, G. J., Khan, S. A., Abadi, M. A., Wild, T. F., Bloom, B. R.
(1999). Mucosal DNA Vaccine Immunization Against Measles with a Highly Attenuated Shigella flexneri Vector. J. Immunol.
162: 1603-1610
[Abstract]
[Full Text]
-
Sixt, N., Cardoso, A., Vallier, A., Fayolle, J., Buckland, R., Wild, T. F.
(1998). Canine Distemper Virus DNA Vaccination Induces Humoral and Cellular Immunity and Protects against a Lethal Intracerebral Challenge. J. Virol.
72: 8472-8476
[Abstract]
[Full Text]